Skip to main content

People in the News: Andrew Last, David Weber

Premium

Affymetrix has appointed Andrew Last to the position of chief operating officer, and named David Weber as its chief commercial officer, the company said in a recent US Securities and Exchange Commission filing.

Last had been executive vice president of Affymetrix's Genetic Analysis business unit, while Weber's previous title was executive vice president of global commercial operations. The company said the organizational changes will enable its CEO Frank Witney to "focus more time on refining the strategic vision and product portfolio of the company as its business continues to diversify and the underlying technologies evolve."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.